PTHL
Pheton Holdings Ltd Class A Ordinary Shares
NASDAQ · Healthcare · Medical - Devices
$0.28
−5.73%Price chart
Feb 20Feb 25Mar 2Mar 5Mar 10Mar 13Mar 18Mar 23
Key dataMar 23, 2026
Open$0.27
From 52W high−99.09%
Volume106322.00
Market cap$4.22M
P/E (TTM)—
P/S (TTM)13.8x
Div yield—
Key dataMar 23, 2026
Open
$0.27
From 52W high
−99.09%
Volume
106322.00
Market cap
$4.22M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.5x
P/E (TTM)
—
RSI (14)
30.5
MomentumView details →
1D Return
−5.73%
YTD Return
−33.10%
SummaryUpdated Jun 1, 2025
Pheton Holdings Ltd (NASDAQ:PTHL) is a Chinese healthcare technology company founded in 1998 and headquartered in Beijing. The company specializes in developing and commercializing advanced treatment planning software and devices for brachytherapy, a specialized form of radiation therapy used in cancer treatment. Operating as a subsidiary of ZJW (BVI) LTD, Pheton has focused on creating proprietary solutions that help medical professionals deliver precise radiation treatment to cancer patients by placing radioactive sources directly inside or near tumors.
Similar companies
Latest newsMore news →
No recent news for PTHL.